Life Science Investing Tenaya Therapeutics Announces New Clinical Data for TN-201 Gene Therapy will be Featured in Late-Breaking Presentation at the American Heart Association Scientific Sessions 2025
Life Science Investing Tenaya Therapeutics to Participate in H.C. Wainwright Genetic Medicines Virtual Conference
Life Science Investing Tenaya Therapeutics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
Life Science Investing Tenaya Therapeutics Presents Interim Data from MyClimb Natural History Study of MYBPC3-associated HCM Pediatric Patients at European Society of Cardiology Congress 2025
